# US 2002/0119551 A1 · ppGpp synthetase and expression systems for improved production of protein of interest

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2002/0119551 A1
- Document ID: US20020119551A1
- Status: Published application
- Kind: A1
- Application number: 09/946,931
- Filed: 2001-09-05
- Published: 2002-08-29
- Earliest claimed: 1997-06-20
- Assignees: Novozymes A/S
- Inventors: Jens Tonne Andersen; Stanislas Dusko Ehrlich
- Web page: https://patentgrep.com/patent/US20020119551A1

## CPC

- C12N 9/1235: {Diphosphotransferases (2.7.6)}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to a novel ppGpp synthetase and expression systems for improved production of proteins of interest in Gram-positive bacteria, involving use of the novel ppGpp synthetase.

## Claims

### Claim 1

An isolated polynucleotide molecule selected from the group consisting of:
(a) polynucleotide molecules encoding a polypeptide having ppGpp synthetase activity and comprising a sequence of nucleotides as shown in SEQ ID NO:1 from nucleotide 21 to nucleotide 2225;
(b) species homologs of (a);
(c) polynucleotide molecules that encode a polypeptide having ppGpp synthetase activity that is at least 70% identical to the amino acid sequence of SEQ ID NO:2 from amino acid residue 1 to amino acid residue 734;
(d) molecules complementary to (a), (b) or (c); and
(e) degenerate nucleotide sequences of (a), (b), (c) or (d).

### Claim 2 (depends on 1)

The isolated polynucleotide molecule of claim 1, wherein the polynucleotide molecule encodes a polypeptide having ppGpp synthetase activity and comprises a sequence of nucleotides as shown in SEQ ID NO:3 from nucleotide 21 to nucleotide 2225.

### Claim 3

An expression vector comprising the following operably linked elements: a transcription promoter; a DNA segment selected from the group consisting of:
(a) polynucleotide molecules encoding a polypeptide having ppGpp synthetase activity and comprising a sequence of nucleotides as shown in SEQ ID NO:1 from nucleotide 21 to nucleotide 2225;
(b) species homologs of (a);
(c) polynucleotide molecules that encode a polypeptide having ppGpp synthetase activity that is at least 70% identical to the amino acid sequence of SEQ ID NO:2 from amino acid residue 1 to amino acid residue 734; and
(d) degenerate nucleotide sequences of (a), (b), or (c); and a transcription terminator.

### Claim 4 (depends on 3)

A cultured cell into which has been introduced an expression vector of claim 3, wherein the cell expresses the polypeptide encoded by the DNA segment.

### Claim 5

An isolated polypeptide having ppGpp synthetase activity selected from the group consisting of:
(a) polypeptide molecules comprising an amino acid sequence as shown in SEQ ID NO:2 from residue 1 to residue 734; and
(b) polypeptide molecules that are at least 70% identical to the amino acids of SEQ ID NO:2 from amino acid residue 1 to amino acid residue 734.

### Claim 6 (depends on 5)

A composition comprising a purified polypeptide of claim 5.

### Claim 7 (depends on 3)

A method of producing a polypeptide having ppGpp synthetase activity comprising:
(a) culturing a cell into which has been introduced an expression vector according to claim 3, whereby the cell expresses a polypeptide encoded by the DNA segment; and
(b) recovering the polypeptide.

### Claim 8 (depends on 5)

An expression system for improved production of at least one protein of interest in gram-positive bacteria, which expression system comprises a gram-positive bacterium expressing smaller than wild-type amounts of a polypeptide of claim 5.

### Claim 9 (depends on 8)

The expression system of claim 8, wherein said species of Bacillus is a Bacillus subtilis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillus thuringiensis, Bacillus clausii, or Bacillus licheniformis.

### Claim 10 (depends on 8)

The expression system of claim 8, wherein the protein of interest is recombinantly produced by use of an expression vector.

### Claim 11 (depends on 8)

The expression system of claim 8, wherein the protein of interest is a homologous protein.

### Claim 12 (depends on 8)

The expression system of claim 8, wherein the protein of interest is a heterologous protein.

### Claim 13 (depends on 10)

The expression system of claim 10, wherein the protein is an exoprotein and is expressed by use of an expression vector.

### Claim 14 (depends on 8)

The expression system of claim 8, wherein the protein of interest is an amylase, bacterial protein toxin, cellulase, CGTase (cyclodextrin gluconotransferase), galactosidase, glucose isomerase, glucose oxidase, glucosyl transferase, laccase, lipase, microbial surface protein, pharmaceutical, phytase, protease, protein disulphide isomerase, pullanase, viral protein, or xylanase.

### Claim 15 (depends on 8)

The expression system of claim 8, wherein the gram-positive bacteria is a strain of Bacillus.

### Claim 16 (depends on 15)

The expression system of claim 15, wherein the strain is a Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus brevis, Bacillus circulans, Bacillus clausii, Bacillus coagulans, Bacillus lautus, Bacillus lentus, Bacillus licheniformis, Bacillus stearothermophilus, Bacillus subtilis, or Bacillus thuringiensis strain.

### Claim 17 (depends on 8)

A method for improved production of at least one protein of interest in a gram-positive bacterium, which method comprises:
(a) culturing an expression system of claim 8; and
(b) purifying the protein of interest from the resulting culture broth or expression system.

### Claim 18 (depends on 17)

The method of claim 17, wherein the culturing is done as a fed-batch fermentation.
